What companies are GNLX's competitors?

Genelux Corporation (GNLX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GNLX compare to its peers?

The peer comparison table on this page shows Genelux Corporation (GNLX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GNLX operate in?

Genelux Corporation (GNLX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GNLX

Genelux Corporation

NASDAQ·Biotechnology · Healthcare

$2.88$0.15+5.49%

After hours·$2.88+0.00%

Market cap$129.14M·Market closed·Aug 27 8:00 PM UTC

Frequently Asked Questions About GNLX

What companies are GNLX's competitors?: Genelux Corporation (GNLX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GNLX compare to its peers?: The peer comparison table on this page shows Genelux Corporation (GNLX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GNLX operate in?: Genelux Corporation (GNLX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GNLX

Genelux Corporation

NASDAQ·Biotechnology · Healthcare

$2.88$0.15+5.49%

After hours·$2.88+0.00%

Market cap$129.14M·Market closed·Aug 27 8:00 PM UTC

Peers


DRTS	Alpha Tau Medical Ltd	$14.81	$1.3B
CADL	Candel Therapeutics, Inc.	$13.75	$1.0B
CTNM	Contineum Therapeutics, Inc.	$17.25	$649.0M
SLN	Silence Therapeutics plc	$13.45	$635.3M
LXEO	Lexeo Therapeutics, Inc. Common Stock	$4.99	$391.8M
LYEL	Lyell Immunopharma, Inc.	$14.61	$358.0M
CLLS	Cellectis S.A.	$3.56	$357.0M
ACIU	AC Immune S.A.	$2.80	$284.5M
ALDX	Aldeyra The	$1.54	$92.9M
MREO	Mereo BioPharma Group plc	$0.27	$43.4M

Frequently Asked Questions About GNLX

What companies are GNLX's competitors?: Genelux Corporation (GNLX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GNLX compare to its peers?: The peer comparison table on this page shows Genelux Corporation (GNLX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GNLX operate in?: Genelux Corporation (GNLX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.